Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.660
-0.030 (-1.78%)
At close: Apr 28, 2026, 4:00 PM EDT
1.650
-0.010 (-0.60%)
Pre-market: Apr 29, 2026, 7:24 AM EDT

Lexicon Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
703418267373360587
Upgrade
Market Cap Growth
279.96%56.54%-28.50%3.58%-38.55%21.91%
Upgrade
Enterprise Value
669367114261255480
Upgrade
Last Close Price
1.661.150.741.531.913.94
Upgrade
PS Ratio
14.128.398.59310.102593.281968.62
Upgrade
PB Ratio
5.613.891.834.013.085.16
Upgrade
P/TBV Ratio
11.166.632.637.694.978.50
Upgrade
EV/Sales Ratio
13.447.373.68216.721833.751610.51
Upgrade
Debt / Equity Ratio
0.580.580.731.140.470.02
Upgrade
Net Debt / Equity Ratio
-0.32-0.32-0.90-0.69-0.71-0.74
Upgrade
Net Debt / EBITDA Ratio
0.700.700.680.370.830.97
Upgrade
Net Debt / FCF Ratio
0.500.500.730.390.920.96
Upgrade
Asset Turnover
0.210.210.120.010.000.00
Upgrade
Inventory Turnover
25.6425.6421.10---
Upgrade
Quick Ratio
4.734.735.345.425.973.92
Upgrade
Current Ratio
4.884.885.445.606.084.02
Upgrade
Return on Equity (ROE)
-39.72%-39.72%-167.66%-168.50%-88.37%-65.01%
Upgrade
Return on Assets (ROA)
-12.65%-12.65%-46.42%-50.67%-37.91%-31.95%
Upgrade
Return on Capital Employed (ROCE)
-29.80%-29.80%-77.40%-86.80%-58.70%-75.90%
Upgrade
Earnings Yield
-7.16%-12.05%-75.07%-47.44%-28.28%-14.96%
Upgrade
FCF Yield
-9.65%-16.24%-67.36%-43.49%-25.02%-15.04%
Upgrade
Buyback Yield / Dilution
-13.44%-13.44%-44.73%-33.42%-13.79%-31.41%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.